6505--Radiopharmaceuticals PLUVICTO / LUTATHERA - Nuclear Med, IND

SOL #: 36C25026N0310Special NoticeSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
250-NETWORK CONTRACT OFFICE 10 (36C250)
DAYTON, OH, 45428, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 29, 2026
2
Action Date
Jan 30, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the VA Healthcare System, Network 10 Contracting Office, intends to award a sole source contract for FDA-approved radioactive therapy drugs, Lu177 PLUVICTO and Lu177 LUTATHERA. The intended vendor is Novartis. This is a Special Notice and not a request for competitive proposals.

Purpose & Scope

The VA requires these unique and highly specialized radioactive therapy drugs, Lu177 PLUVICTO and Lu177 LUTATHERA, which are FDA-approved and have significantly changed standard patient care guidelines for prostate cancer treatment. The government believes only Novartis possesses the required capabilities to meet this requirement, citing GSAR 538.7104-3(b)(1)(ii), which allows for sole source procurement when supplies or services are unique or highly specialized.

Contract Details

  • Type: One-year Firm Fixed-Price contract.
  • Intended Vendor: Novartis, Route 10, East Hanover, NJ, 07936.
  • NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing).
  • Product Service Code: 6505 (Drugs And Biologicals).

Set-Aside

This is a sole source procurement; therefore, no set-aside designation applies.

Key Dates & Information

  • Response Date for Notice: February 2, 2026, 3 PM Eastern Time, New York, USA.
  • Published Date: January 29, 2026.
  • Contracting Office: Department of Veterans Affairs, Dayton VA Medical Center, Kettering, OH 45409-1337.
  • Point of Contact: Todd Cress (todd@va.gov, 937-503-4194).

Important Note

This notice of intent is not a request for competitive proposals, a solicitation, or a request for offers. It serves solely as an announcement of the government's intent to negotiate with a single source. Interested parties who believe they can meet this requirement may submit a capability statement by the response date.

People

Points of Contact

Aroosa Shah (Centeva)eCMS ConsultantPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Jan 29, 2026
6505--Radiopharmaceuticals PLUVICTO / LUTATHERA - Nuclear Med, IND | GovScope